Tech Company Financing Transactions

TwinStrand Biosciences Funding Round

TwinStrand Biosciences secured a $50 million Series B funding round on 5/7/2021. Investors included Section 32, Alexandria Venture Investments and Janus Henderson Investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare IT

Mailing Address

3131 Elliott Ave. 750
Seattle, WA 98121
USA

Phone

Undisclosed

Website

www.twinstrandbio.com

Email Address

Not Recorded

Overview

At TwinStrand Biosciences we are using Duplex Sequencing Technology to detect ultra-rare variants that are invisible by other sequencing approaches. We are applying our technology to a new generation of high-accuracy clinical diagnostics and innovative tools for scientific discovery.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jesse Salk

        

Chief Operating Officer

Elena Cant

        

Vice President

Kellie Bickel

        

VP - General Counsel

Kissy Dabbs

        

VP - Marketing

Alex Lindell

        

VP - Sales

Brett Fritz

        

Browse more venture capital transactions:

Prev: 5/7/2021: Pliant venture capital transaction
Next: 5/7/2021: Astrocyte Pharmaceuticals venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary